Elevated plasma miR‐210 expression is associated with atypical genitalia in patients with 46,XY differences in sex development

Abstract Background Differences of sex development (DSD) is a term used for conditions in which the chromosomal, gonadal or phenotypical sex is atypical. 46,XY DSD patients frequently present undervirilized external genitalia. The expression of different miRNAs in many organs of the male genital sys...

Full description

Bibliographic Details
Main Authors: Felipe Martins Elias, Mirian Yumi Nishi, Maria Helena Palma Sircili, Rafael Loch Bastista, Nathalia Lisboa Gomes, Maria Tereza Martins Ferrari, Elaine Maria Frade Costa, Francisco Tibor Denes, Berenice Bilharinho Mendonca, Sorahia Domenice
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Molecular Genetics & Genomic Medicine
Subjects:
Online Access:https://doi.org/10.1002/mgg3.2084
_version_ 1827965158060720128
author Felipe Martins Elias
Mirian Yumi Nishi
Maria Helena Palma Sircili
Rafael Loch Bastista
Nathalia Lisboa Gomes
Maria Tereza Martins Ferrari
Elaine Maria Frade Costa
Francisco Tibor Denes
Berenice Bilharinho Mendonca
Sorahia Domenice
author_facet Felipe Martins Elias
Mirian Yumi Nishi
Maria Helena Palma Sircili
Rafael Loch Bastista
Nathalia Lisboa Gomes
Maria Tereza Martins Ferrari
Elaine Maria Frade Costa
Francisco Tibor Denes
Berenice Bilharinho Mendonca
Sorahia Domenice
author_sort Felipe Martins Elias
collection DOAJ
description Abstract Background Differences of sex development (DSD) is a term used for conditions in which the chromosomal, gonadal or phenotypical sex is atypical. 46,XY DSD patients frequently present undervirilized external genitalia. The expression of different miRNAs in many organs of the male genital system has been reported, and these miRNAs have been associated with testicular function and its disorders, but no description has been related to DSD conditions. This study aimed to evaluate the plasma expression of miR‐210 in 46,XY DSD patients who presented atypical genitalia at birth. Methods Eighteen 46,XY DSD patients who presented atypical genitalia (undescended testis and/or hypospadias, bifid scrotum or micropenis) at birth and 36 male control individuals were selected. Plasma levels of miR‐210 and reference miR‐23a were measured using RT‐qPCR and the data were analysed by the 2−ΔCt method. Results MiR‐210 plasma levels were significantly higher in 46,XY DSD patients with atypical genitalia than in male control subjects (p = 0.0024). A positive association between miR‐210 levels and the presence of cryptorchidism and hypospadias (p = 0.0146 and p = 0.0223) was found in these patients. Significantly higher levels of miR‐210 were observed in patients with 46,XY DSD and cryptorchidism than in control subjects (p = 0.0118). These results are in agreement with previous literature reports, in which increased levels of miR‐210 expression were observed in human testicular tissue from adult males with undescended testes in comparison with samples of descended testes. Conclusion Our study showed a positive association between the presence of atypical genitalia and plasma levels of miR‐210 expression in the group of patients with 46,XY DSD of unknown aetiology studied. These findings contribute to reveal a new perspective on the role of miRNAs in the development of male external genitalia and the broad spectrum of phenotypes presented by patients with 46,XY DSD.
first_indexed 2024-04-09T17:27:32Z
format Article
id doaj.art-d2ae15f6af7a420190fce318df8acba6
institution Directory Open Access Journal
issn 2324-9269
language English
last_indexed 2024-04-09T17:27:32Z
publishDate 2022-12-01
publisher Wiley
record_format Article
series Molecular Genetics & Genomic Medicine
spelling doaj.art-d2ae15f6af7a420190fce318df8acba62023-04-18T10:16:08ZengWileyMolecular Genetics & Genomic Medicine2324-92692022-12-011012n/an/a10.1002/mgg3.2084Elevated plasma miR‐210 expression is associated with atypical genitalia in patients with 46,XY differences in sex developmentFelipe Martins Elias0Mirian Yumi Nishi1Maria Helena Palma Sircili2Rafael Loch Bastista3Nathalia Lisboa Gomes4Maria Tereza Martins Ferrari5Elaine Maria Frade Costa6Francisco Tibor Denes7Berenice Bilharinho Mendonca8Sorahia Domenice9Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular LIM‐42 Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo São Paulo BrazilUnidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular LIM‐42 Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo São Paulo BrazilUnidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular LIM‐42 Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo São Paulo BrazilUnidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular LIM‐42 Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo São Paulo BrazilUnidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular LIM‐42 Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo São Paulo BrazilUnidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular LIM‐42 Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo São Paulo BrazilUnidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular LIM‐42 Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo São Paulo BrazilDepartamento de Urologia do Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo São Paulo BrazilUnidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular LIM‐42 Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo São Paulo BrazilUnidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular LIM‐42 Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo São Paulo BrazilAbstract Background Differences of sex development (DSD) is a term used for conditions in which the chromosomal, gonadal or phenotypical sex is atypical. 46,XY DSD patients frequently present undervirilized external genitalia. The expression of different miRNAs in many organs of the male genital system has been reported, and these miRNAs have been associated with testicular function and its disorders, but no description has been related to DSD conditions. This study aimed to evaluate the plasma expression of miR‐210 in 46,XY DSD patients who presented atypical genitalia at birth. Methods Eighteen 46,XY DSD patients who presented atypical genitalia (undescended testis and/or hypospadias, bifid scrotum or micropenis) at birth and 36 male control individuals were selected. Plasma levels of miR‐210 and reference miR‐23a were measured using RT‐qPCR and the data were analysed by the 2−ΔCt method. Results MiR‐210 plasma levels were significantly higher in 46,XY DSD patients with atypical genitalia than in male control subjects (p = 0.0024). A positive association between miR‐210 levels and the presence of cryptorchidism and hypospadias (p = 0.0146 and p = 0.0223) was found in these patients. Significantly higher levels of miR‐210 were observed in patients with 46,XY DSD and cryptorchidism than in control subjects (p = 0.0118). These results are in agreement with previous literature reports, in which increased levels of miR‐210 expression were observed in human testicular tissue from adult males with undescended testes in comparison with samples of descended testes. Conclusion Our study showed a positive association between the presence of atypical genitalia and plasma levels of miR‐210 expression in the group of patients with 46,XY DSD of unknown aetiology studied. These findings contribute to reveal a new perspective on the role of miRNAs in the development of male external genitalia and the broad spectrum of phenotypes presented by patients with 46,XY DSD.https://doi.org/10.1002/mgg3.2084atypical genitaliacryptorchidismdifferences in sex developmenthypospadiasMicroRNAmiR‐210
spellingShingle Felipe Martins Elias
Mirian Yumi Nishi
Maria Helena Palma Sircili
Rafael Loch Bastista
Nathalia Lisboa Gomes
Maria Tereza Martins Ferrari
Elaine Maria Frade Costa
Francisco Tibor Denes
Berenice Bilharinho Mendonca
Sorahia Domenice
Elevated plasma miR‐210 expression is associated with atypical genitalia in patients with 46,XY differences in sex development
Molecular Genetics & Genomic Medicine
atypical genitalia
cryptorchidism
differences in sex development
hypospadias
MicroRNA
miR‐210
title Elevated plasma miR‐210 expression is associated with atypical genitalia in patients with 46,XY differences in sex development
title_full Elevated plasma miR‐210 expression is associated with atypical genitalia in patients with 46,XY differences in sex development
title_fullStr Elevated plasma miR‐210 expression is associated with atypical genitalia in patients with 46,XY differences in sex development
title_full_unstemmed Elevated plasma miR‐210 expression is associated with atypical genitalia in patients with 46,XY differences in sex development
title_short Elevated plasma miR‐210 expression is associated with atypical genitalia in patients with 46,XY differences in sex development
title_sort elevated plasma mir 210 expression is associated with atypical genitalia in patients with 46 xy differences in sex development
topic atypical genitalia
cryptorchidism
differences in sex development
hypospadias
MicroRNA
miR‐210
url https://doi.org/10.1002/mgg3.2084
work_keys_str_mv AT felipemartinselias elevatedplasmamir210expressionisassociatedwithatypicalgenitaliainpatientswith46xydifferencesinsexdevelopment
AT mirianyuminishi elevatedplasmamir210expressionisassociatedwithatypicalgenitaliainpatientswith46xydifferencesinsexdevelopment
AT mariahelenapalmasircili elevatedplasmamir210expressionisassociatedwithatypicalgenitaliainpatientswith46xydifferencesinsexdevelopment
AT rafaellochbastista elevatedplasmamir210expressionisassociatedwithatypicalgenitaliainpatientswith46xydifferencesinsexdevelopment
AT nathalialisboagomes elevatedplasmamir210expressionisassociatedwithatypicalgenitaliainpatientswith46xydifferencesinsexdevelopment
AT mariaterezamartinsferrari elevatedplasmamir210expressionisassociatedwithatypicalgenitaliainpatientswith46xydifferencesinsexdevelopment
AT elainemariafradecosta elevatedplasmamir210expressionisassociatedwithatypicalgenitaliainpatientswith46xydifferencesinsexdevelopment
AT franciscotibordenes elevatedplasmamir210expressionisassociatedwithatypicalgenitaliainpatientswith46xydifferencesinsexdevelopment
AT berenicebilharinhomendonca elevatedplasmamir210expressionisassociatedwithatypicalgenitaliainpatientswith46xydifferencesinsexdevelopment
AT sorahiadomenice elevatedplasmamir210expressionisassociatedwithatypicalgenitaliainpatientswith46xydifferencesinsexdevelopment